TMRW LIFE SCIENCES RAISES $25 MILLION IN SERIES B FUNDING LED BY 5AM VENTURES
TMRW Life Sciences ("TMRW"), creator of ivfOS™, an integrated platform for automated, software-guided embryology and cryo-management, announced it has closed $25 million in Series B funding led by 5AM Ventures. This recent funding brings total investment in TMRW to $39 million over the past 12 months. TMRW provides a 100% physical and digital chain of custody, protecting and tracking eggs, embryos, and sperm through RFID-enabled technology. With 300 million global births predicted as the result of IVF by 2100, the need for IVF clinics to adopt an automated method for managing reproductive cells has never been more crucial.
PLAYON! SPORTS RAISES $25 MILLION IN SERIES B FUNDING
PlayOn! Sports (PlayOn) announced that it has raised Series B funding of $25 million led by venture investment firm BIP Capital. New investors in the funding round include Jeff Vinik, Teall Capital, and Crossover. The capital will be used to further the company's growth by accelerating the deployment of the Pixellot automated production solution throughout the high school market, as well as for additional investments in its consumer products and automated marketing infrastructure. There are currently more than 4,000 Pixellot units in high schools across the country producing in excess of 150,000 live games annually without the need for human involvement. Subscription revenue has grown by more than 100 percent year over year.
COGITATIVO RAISES $18.5M SERIES B ROUND OF FINANCING
Cogitativo, Inc., the first-to-market data-science-as-a-service (DSaaS) company for healthcare service organizations, announced the closing of an $18.5 million Series B round of financing.The financing was led by Wells Fargo Strategic Capital (WFSC), a wholly-owned subsidiary of Wells Fargo & Company (NYSE: WFC), and additional funding was provided by Claritas Capital. This investment will support product acceleration of AI-driven solutions to detect and remediate areas of waste and inefficiency in the arrangement and financing of healthcare.In the last two years, Cogitativo has more than tripled in size and introduced new DSaaS..
LEVELSET RAISES $30 MILLION TO END SLOW PAYMENT AND CASH FLOW PROBLEMS IN CONSTRUCTION
Levelset, the platform that helps contractors get paid faster and eliminate cash stresses, announced an additional $30 million round of funding led by Horizons Ventures with participation from S3 Ventures, Altos Ventures, Operating Venture Capital, Michael Gollner, and Darren Bechtel of Brick & Mortar Ventures. Horizons Ventures' Bart Swanson will join Levelset's Board of Directors. Levelset has raised $47 million to date. Cash pains are severe for millions of contractors across the world who exchange over $12 trillion dollars of payments annually.
SUMMERSALT RAISES $17.3M SERIES B TO FUEL EXPANSION
Summersalt, the St. Louis based direct-to-consumer travelwear brand announced that it has raised a $17.3M Series B, led by Mercato Partners, with plans to expand into additional apparel categories following the brand's overwhelming success in the swimwear category and recent travelwear launch. Additional participants in the round include Founders Fund, Lewis and Clark Ventures, Revolution's Rise of the Rest Seed Fund, Dundee Venture Capital, and Victress Capital. This round brings Summersalt's total funding to $26M.
DOMIO RAISES $100 MILLION IN SERIES B FUNDING TO ACCELERATE GROWTH
Domio, the New York-based technology-powered apartment-hotel brand, has announced that it has raised $100 million in Series B funding (an even combination of equity and debt).The equity round was led by GGV Capital in August 2019, with participation from additional investors, including: Eldridge Industries, 3L Capital, Cain International, Tribeca Venture Partners, Softbank NY, Tenaya Capital and Upper90. The lead debt investor was Upper90, a New York-based credit fund specializing in providing growth capital. Launched three years ago in August 2016, Domio operates in 12 U.S. markets, most recently expanding its footprint into key flagship cities, including: Miami, Philadelphia and Phoenix. Domio's apartment-hotel rooms are five times larger the average size of U.S. hotel rooms, making them perfect for groups, families and business travelers, and cost about 25 percent less than traditional hotels.
WILLOW RAISES ADDITIONAL $20 MILLION TO FUEL GROWTH AND MAXIMIZE CHANNEL AVAILABILITY
Willow, the femtech leader that changed the way women pump with the first ever quiet, all-in-one, in-bra wearable breast pump, has announced that is has raised an additional $20 million in funding. The investment was led by longtime investors NEA and Meritech Capital Partners as well as Lightstone Ventures and others. The company's total capital raised to date is now $100 million. The additional funding will be used to fuel advanced product development for next generation products and further Willow's expansion into retail, insurance and international channels in order to reach more moms and further the mission of bringing joy to motherhood.
WHYHOTEL SECURES OVER $20M IN SERIES B FUNDING
WhyHotel, an alternative lodging service that operates pop-up hotels in newly built, luxury apartment buildings, recently announced it has secured over $20 million in Series B funding. he funding round was led by Harbert Growth Partners with participation from Camber Creek, Highland Capital Partners, Working Lab Capital, Geolo Capital, Revolution's Rise of the Rest Seed Fund, and Mark Nunnelly, former Managing Director of Bain Capital Partners. The funds will be used to expand WhyHotel's footprint, allowing both building owners and customers to capitalize on its proven, unique business model nationwide. WhyHotel's total funding now stands at over $35M since its inception in 2017. The company plans to continue to accelerate the launch of pop-ups across the U.S. in 2020 and lay the groundwork for building its own high-rise developments that bring the concept into buildings on a permanent basis via Hospitality Living.
CF PHARMTECH CLOSES US$ 90 MILLION ROUND TO ACCELERATE DEVELOPMENT OF RESPIRATORY DRUGS
CF PharmTech, Inc., a pharmaceutical company with a vision to provide quality and affordable respiratory drug products globally, announced it has raised a $90 million Series E investment led by New Alliance Capital. The investment included participation from new investors CR-CP Life Science Fund, Finnova Capital, GT Capital, Co-stone Asset Management, Xiangcheng Financial Holdings, Everest Venture Capital, and existing investors, such as Oriza Holdings, Longmen Venture Capital, GTJA Investment and CMB International. The completion of this round of funding reflects the strong support from China's investors to fuel high-caliber pharmaceutical companies that have a strong global competitive edge, and will allow CF PharmTech to bring products in its pipeline to market. CEC Capital served as the exclusive financial adviser to CF PharmTech.
ELYSIUM HEALTH™ ANNOUNCES $40 MILLION SERIES C FINANCING LED BY GISEV FAMILY OFFICE
Elysium Health, Inc.,™ a life sciences company developing clinically validated health products based on advancements in scientific research, today announced $40 million in Series C equity and debt financing led by GISEV Family Office (Giuliani SpA / Royalty Pharma / HBM Healthcare / Nogra Pharma) and joined by Mayo Clinic Ventures and leading venture lender Western Technology Investment (WTI), the first debt lenders to Stemcentrx, Health IQ, and Practice Fusion. Returning investors include General Catalyst, Morningside Ventures, and Breyer Capital. The funding will support the expansion of Elysium Health's product portfolio and pipeline – which now includes tests as well as clinically validated interventions – the continued growth of its customer base, and additional human clinical trials to evaluate the safety and efficacy of new and existing products.
RIVIAN ANNOUNCES $1.3 BILLION FUNDING ROUND LED BY T. ROWE PRICE
Rivian has closed an investment round of $1.3 billion. The financing was led by funds and accounts advised by T. Rowe Price Associates, Inc.Amazon, Ford Motor Company and funds managed by BlackRock also participated in the round. The investment announcement is Rivian's fourth of 2019. In February, Rivian announced a $700 million funding round led by Amazon. In April, Rivian announced that Ford Motor Company invested $500 million. In September, Cox Automotive announced its $350 million investment in Rivian, complemented by plans to collaborate on logistics and service
BILLINGPLATFORM RAISES $10 MILLION SERIES B TO GROW BILLING SOFTWARE BUSINESS
BillingPlatform, a global, cloud-based monetization and billing software provider, has raised $10 million in Series B funding from Columbia Capital. The money will be used to continue product development, customer success programs, and go-to-market efforts. BillingPlatform has now raised $14 million from Columbia since 2017. According to MGI Research, the market for monetization software tools is growing dramatically and represents expanding opportunity with a total market exceeding $172 billion to 2022.
SHENANDOAH VALLEY ORGANIC RAISES $15M NEW FUNDING TO DRIVE CONTINUED GROWTH
Shenandoah Valley Organic (SVO) announced it closed a $15 million funding round led by NRV, with participation from Open Prairie, as well as existing investors S2G Ventures and Middleland Capital's VTC Innovation Fund. Founded in 2014 by CEO Corwin Heatwole, SVO produces the Farmer Focus™ brand, a mission-based, values-driven organic meat brand that provides best in class traceability. A sixth-generation farmer himself, Heatwole revolutionized the industry by creating sustainable, innovative partnerships between SVO and family farms that allows farmers to retain ownership and grow profitability while also providing traceable, organic meat.
METABOMED COMPLETES A $12.5 MILLION RAISE IN TO ADVANCE ITS LEAD PROGRAM
Metabomed, a leading cancer metabolism company completed a financing of $12.5 million bringing the total raised to date to $30 million. The company announced that it has declared a clinical candidate for its first-in-class program targeting the inhibition of the AcetylCoA Short chain Synthase 2 enzyme (ACSS2) in cancers dependent on acetate metabolism. The financing round was led by Yonjin Venture, joined by M Ventures, Pfizer Ventures, Pontifax Venture Fund, Boehringer Ingelheim Venture Fund and Arkin Bio.
Media Partner - News and Articles>
CEO OF THE YEAR AWARDS - THE BEST LEADERS OF 2019
WORLD BIZ MAGAZINE - AUTUMN 2019 ISSUE
WORLD BANK AWARDS 2019 - THE BEST BANKS FOR BUSINESS
CSR LEADER 100 - THE MOST RESPONSIBLE COMPANIES
WORLD FDI AWARDS 2019 - THE BEST INVESTMENT DESTINATIONS
DESTIG ART INVESTMENT: TOP EMERGING ARTISTS